Which dialysis method works best for ICU kidney failure? a Head-to-Head test
NCT ID NCT06032884
First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time
Summary
This trial compares two ways of filtering blood in critically ill patients with severe acute kidney injury: intermittent hemodialysis (done in sessions) and continuous renal replacement therapy (done non-stop). The goal is to see if the intermittent method is just as good as the continuous one in preventing death, lasting kidney damage, or the need for ongoing dialysis at 90 days. About 1,000 ICU adults on breathing support or blood pressure medication will be randomly assigned to one of the two methods. The study aims to help doctors choose the best dialysis approach for these very sick patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Two dialysis procedures: intermittent hemodialysis (IHD) and continuous renal replacement therapy (CRRT)
- What this could lead to
- If intermittent hemodialysis proves as effective as continuous therapy, it could offer a simpler, more flexible treatment option for ICU patients with severe kidney injury.
- What could go wrong
- The trial is large but still experimental; results may not show a clear difference, and both methods carry risks like low blood pressure or clotting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
554 people
The number who actually took part.
- Started
-
Oct 2023
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adults (\> or= 18 years old) in ICU 2. Receiving (or who have received) invasive mechanical ventilation and/or catecholamine infusion 3. Availability of both equipment IHD and CRRT (in the investigational center at the time of inclusion) 4. One of the 2 following situations 4.a: Either at least one of the 3 following complications of AKI\* (whatever the KDIGO stage): persistent severe hyperkalaemia despite medical treatment, persistent severe metabolic acidosis despite medical treatment or severe pulmonary edema due to fluid overload despite diuretic therapy 4.b: Or an AKI stage 3 of KDIGO with one of the 2 following criteria: serum urea concentration\>40mmol/L or persistence of oligo-anuria\>3 days \*Definitions of these complication are provided in the main text (Section 7.1) 5. Affiliation of social security system 6. Written consent obtained from the patients (from a support person, family member or a close relative if the patient is not able to expressing and sign consent) or inclusion without initial consent in case of emergency, if the patient is not able to express his/her consent and in the absence of support person, family member or a close relative Exclusion Criteria: * Moribund state (patient likely to die within 24h) * Previous inclusion in the study * Subject deprived of freedom, or under a legal protective measure (example: patients under guardianship or curatorship) * Subject receiving state medical aid * Pregnancy or breastfeeding woman * Patient included in another research trial on AKI * Advanced chronic kidney disease (CKD) defined by an estimated GFR\<20 mL/min/1.73 m2 * Presence of a drug overdose or of a dialyzable toxin that necessitates RRT (because IHD may be preferable in these conditions). * Presence or clinical suspicion of renal obstruction, rapidly progressive glomerulonephritis, vasculitis, thrombotic microangiopathy or acute interstitial nephritis * Brain injured patients or other causes of increased intracranial pressure * Fulminant hepatic failure
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute kidney injury are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
c 001 Avicenne Service de réanimation médico chirurgicale
Bobigny, Bobigny, 93000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Common Anti-Nausea drugs under scrutiny for kidney risk during chemo
- Heart attack delay may signal kidney risk after angioplasty
- ICU kidney injury: does the pattern predict lasting damage?
- Can a kidney ultrasound scan warn of kidney damage after heart bypass surgery?
- Two blood tests may separate real kidney harm from a false alarm
- Can watching kidney oxygen during liver surgery keep kidneys safe?